RhumbLine Advisers’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.73M | Buy |
70,753
+2,026
| +3% | +$278K | 0.01% | 1062 |
|
|
2025
Q1 | $12.4M | Sell |
68,727
-409
| -0.6% | -$73.7K | 0.01% | 924 |
|
|
2024
Q4 | $10.8M | Sell |
69,136
-1,173
| -2% | -$184K | 0.01% | 1012 |
|
|
2024
Q3 | $12.8M | Sell |
70,309
-1,376
| -2% | -$250K | 0.01% | 948 |
|
|
2024
Q2 | $13.2M | Buy |
71,685
+39,586
| +123% | +$7.27M | 0.01% | 896 |
|
|
2024
Q1 | $5.71M | Buy |
32,099
+314
| +1% | +$55.9K | 0.01% | 1347 |
|
|
2023
Q4 | $3.94M | Sell |
31,785
-618
| -2% | -$76.7K | ﹤0.01% | 1560 |
|
|
2023
Q3 | $3.76M | Buy |
32,403
+1,388
| +4% | +$161K | ﹤0.01% | 1513 |
|
|
2023
Q2 | $3.64M | Sell |
31,015
-1,454
| -4% | -$171K | ﹤0.01% | 1574 |
|
|
2023
Q1 | $2.6M | Buy |
32,469
+635
| +2% | +$50.8K | ﹤0.01% | 1674 |
|
|
2022
Q4 | $2.52M | Buy |
31,834
+711
| +2% | +$56.3K | ﹤0.01% | 1658 |
|
|
2022
Q3 | $2.17M | Buy |
31,123
+2,638
| +9% | +$184K | ﹤0.01% | 1714 |
|
|
2022
Q2 | $1.87M | Buy |
28,485
+4,646
| +19% | +$305K | ﹤0.01% | 1796 |
|
|
2022
Q1 | $1.59M | Buy |
23,839
+2,172
| +10% | +$145K | ﹤0.01% | 1925 |
|
|
2021
Q4 | $1.52M | Buy |
21,667
+123
| +0.6% | +$8.61K | ﹤0.01% | 2025 |
|
|
2021
Q3 | $1.13M | Buy |
21,544
+860
| +4% | +$44.9K | ﹤0.01% | 2169 |
|
|
2021
Q2 | $1.41M | Buy |
20,684
+5,685
| +38% | +$387K | ﹤0.01% | 2101 |
|
|
2021
Q1 | $1.16M | Sell |
14,999
-111
| -0.7% | -$8.56K | ﹤0.01% | 2139 |
|
|
2020
Q4 | $907K | Buy |
15,110
+1,435
| +10% | +$86.1K | ﹤0.01% | 2179 |
|
|
2020
Q3 | $589K | Sell |
13,675
-1,520
| -10% | -$65.5K | ﹤0.01% | 2211 |
|
|
2020
Q2 | $629K | Buy |
15,195
+3,020
| +25% | +$125K | ﹤0.01% | 2244 |
|
|
2020
Q1 | $526K | Buy |
12,175
+867
| +8% | +$37.5K | ﹤0.01% | 2141 |
|
|
2019
Q4 | $626K | Buy |
11,308
+1,038
| +10% | +$57.5K | ﹤0.01% | 2273 |
|
|
2019
Q3 | $357K | Buy |
10,270
+1,614
| +19% | +$56.1K | ﹤0.01% | 2484 |
|
|
2019
Q2 | $349K | Buy |
+8,656
| New | +$349K | ﹤0.01% | 2536 |
|